Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Nov 21 424B5 Prospectus supplement for primary offering
- 15 Oct 21 424B4 Prospectus supplement with pricing info
- 13 Oct 21 EFFECT Notice of effectiveness
- 7 Oct 21 S-1/A IPO registration (amended)
- 6 Oct 21 S-1/A IPO registration (amended)
-
30 Aug 21 S-1/A IPO registration (amended)
- 28 Jun 21 S-1 IPO registration
BBLG similar filings
Filing view
External links
Exhibit 99.2
Consent of Director Nominee
Bone Biologics Corporation is filing a Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended, or the Securities Act, in connection with the public offering of Common Stock and Warrants of Bone Biologics Corporation. In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a Director nominee of Bone Biologics Corporation in the Registration Statement, as may be amended from time to time. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
/s/ Erick Lucera | |
Name: |